Both univariate and multivariate Cox regression analyses indicated that LAIR‐1 overexpression is an independent adverse factor affecting the prognosis of glioma patients, which was also confirmed in two other validated cohorts. This evidence concerns the gene LAIR1 and central nervous system cancer.